13F filer · CIK 1978599
Allostery Investments LP
Stamford, CT · filing since Q4 2024 · last filing Nov 14, 2025
Reported value
$0
$-7.9M vs prior
Positions
1
New / sold out
1 / 20
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $7.9M
Top-10 weight
–
Biggest buys vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | 0 | 0 | – | – |
Biggest sells vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ABIVAX SA | -167,350 | -100.0% | $-1.3M |
| Sold out | AKERO THERAPEUTICS INC | -22,500 | -100.0% | $-1.2M |
| Sold out | AMYLYX PHARMACEUTICALS INC | -120,119 | -100.0% | $-770.0K |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -52,500 | -100.0% | $-689.9K |
| Sold out | EVOLUS INC | -60,000 | -100.0% | $-552.6K |
| Sold out | REZOLUTE INC | -119,294 | -100.0% | $-532.1K |
| Sold out | MERUS N V | -9,000 | -100.0% | $-473.4K |
| Sold out | KALVISTA PHARMACEUTICALS INC | -40,000 | -100.0% | $-452.2K |
| Sold out | FULCRUM THERAPEUTICS INC | -40,353 | -100.0% | $-277.6K |
| Sold out | APOGEE THERAPEUTICS INC | -6,000 | -100.0% | $-260.6K |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | 00 | 0 | $0 | – |